Want to join the conversation?
$GILD's total product sales in 2015 were $32.2Bil versus $24.5Bil in 2014, mainly due to sales of Harvoni, partially offset by a decrease in sales of Sovaldi. US product sales in 2015 were $21.2Bil. Europe product sales were $7.2Bil. Sales in other international locations grew to $3.8Bil, mainly due to sales of Sovaldi and Harvoni in Japan.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.
$VZ down more than 2% after a disappointing third quarter. A lot of uncertainty on the Yahoo deal too.